136 related articles for article (PubMed ID: 36250952)
1. Prostate Specific Antigen Testing Behaviors for Prostate Cancer Screening Among U.S. Immigrants: A Cross-sectional Analysis Using the National Health Interview Survey.
Hansen NF; Linscott JA; Hayn MH; Ryan ST; Sammon JD
J Urol; 2023 Jan; 209(1):161-169. PubMed ID: 36250952
[TBL] [Abstract][Full Text] [Related]
2. Citizenship, length of stay, and screening for breast, cervical, and colorectal cancer in women, 2000-2010.
Miranda PY; Yao N; Snipes SA; BeLue R; Lengerich E; Hillemeier MM
Cancer Causes Control; 2017 Jun; 28(6):589-598. PubMed ID: 28364196
[TBL] [Abstract][Full Text] [Related]
3. Temporal and Racial Trends in Prostate-specific Antigen Screening for U.S. Men With a Family History of Prostate Cancer.
Dalela D; Malchow T; Butaney M; Majdalany S; Corsi NJ; Rakic I; Sood A; Rogers C; Abdollah F
Urol Pract; 2023 Sep; 10(5):484-492. PubMed ID: 37347799
[TBL] [Abstract][Full Text] [Related]
4. Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey.
Johnson JA; Moser RP; Ellison GL; Martin DN
J Community Health; 2021 Apr; 46(2):389-398. PubMed ID: 33064229
[TBL] [Abstract][Full Text] [Related]
5. The effect of limited english proficiency on prostate-specific antigen screening in American men.
Stone BV; Labban M; Beatrici E; Filipas DK; Frego N; Qian ZJ; Voleti SS; Osman NY; Pomerantz MM; Lipsitz SR; Feldman AS; Kibel AS; Cole AP; Trinh QD
World J Urol; 2024 Jan; 42(1):54. PubMed ID: 38244128
[TBL] [Abstract][Full Text] [Related]
6. Low-Value Prostate-Specific Antigen Screening in Older Males.
Kalavacherla S; Riviere P; Javier-DesLoges J; Banegas MP; McKay RR; Murphy JD; Rose BS
JAMA Netw Open; 2023 Apr; 6(4):e237504. PubMed ID: 37040113
[TBL] [Abstract][Full Text] [Related]
7. Does a prior cancer diagnosis impact PSA testing? Results from the National Health Interview Survey.
Lazarovich A; Chandrasekar T; Basnet A; Bratslavsky G; Goldberg H
Can J Urol; 2023 Jun; 30(3):11551-11557. PubMed ID: 37344467
[TBL] [Abstract][Full Text] [Related]
8. Effects of length of stay and language proficiency on health care experiences among immigrants in Canada and the United States.
Lebrun LA
Soc Sci Med; 2012 Apr; 74(7):1062-72. PubMed ID: 22326103
[TBL] [Abstract][Full Text] [Related]
9. Prostate and Colorectal Cancer Screening Uptake among US and Foreign-Born Males: Evidence from the 2015 NHIS Survey.
Ilunga Tshiswaka D; Donley T; Okafor A; Memiah P; Mbizo J
J Community Health; 2017 Jun; 42(3):612-623. PubMed ID: 27838809
[TBL] [Abstract][Full Text] [Related]
10. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.
Lin K; Lipsitz R; Miller T; Janakiraman S;
Ann Intern Med; 2008 Aug; 149(3):192-9. PubMed ID: 18678846
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
12. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
13. Disparities in preventive health behaviors among non-Hispanic White men: heterogeneity among foreign-born Arab and European Americans.
Dallo FJ; Kindratt TB
Am J Mens Health; 2015 Mar; 9(2):124-31. PubMed ID: 24780937
[TBL] [Abstract][Full Text] [Related]
14. Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening.
Leapman MS; Wang R; Park H; Yu JB; Sprenkle PC; Cooperberg MR; Gross CP; Ma X
JAMA Oncol; 2022 Jan; 8(1):41-47. PubMed ID: 34762100
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing use of the prostate-specific antigen screening test in primary care.
Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific Antigen Testing in Men with Disabilities: A Cross-sectional Analysis of the Health Information National Trends Survey.
Leong JY; Pinkhasov R; Chandrasekar T; Shapiro O; Daneshvar M; Jacob J; Sanford T; Bratslavsky G; Goldberg H
Eur Urol Focus; 2022 Sep; 8(5):1125-1132. PubMed ID: 34332951
[TBL] [Abstract][Full Text] [Related]
17. Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending.
Kim DD; Daly AT; Koethe BC; Fendrick AM; Ollendorf DA; Wong JB; Neumann PJ
JAMA Netw Open; 2022 Nov; 5(11):e2243449. PubMed ID: 36413364
[TBL] [Abstract][Full Text] [Related]
18. Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys.
Li J; Ding H; Richards TB; Martin I; Kobrin S; Marcus PM
J Am Board Fam Med; 2018; 31(4):658-662. PubMed ID: 29986994
[TBL] [Abstract][Full Text] [Related]
19. Use of the prostate-specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions.
Shahangian S; Sharma KP; Fan L; Siegel DA
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1365. PubMed ID: 33934557
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
